Favourites   Have ideas?  Sign in / Register

Positive:   Surgery ↓10.58   Country: Singapore ↓9.49   Country: Switzerland ↓8.88 «See more»   Agritech ↑11.89   Animals ↑45.43   Pets ↑45.43

Negative:   Bad infrastructure  ↑5.1   Alcohol ↑8.41


Biopharma segment

ABUS Arbutus Biopharma Corporation - Common Stock 1.23% up -7.33% 8.56 + Biopharma, Medicine, Hepatitis


Last highlighted: #ABUS SEC report: Arbutus Biopharma Corp Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Arbutus Biopharma Corp -- SEC File Number 211148337
+ My List
ACER Acer Therapeutics Inc. - Common Stock -1.92% up -8.21% 6.29 + Medicine, Biopharma

+ My List
ACIU AC Immune SA - Common Stock -8.88% down -7.88% -1 + Disease: Neurology/Alzheimer/Parkinson's, Biopharma, Country: Switzerland


Last highlighted: #ACIU SEC report: AC Immune SA Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by AC Immune SA -- SEC File Number 211142337
+ My List
ACRS Aclaris Therapeutics, Inc. - Common Stock -7.14% down -5.41% -1.73 + Immunology, Biopharma, Medicine


Last highlighted: #ACRS SEC report: Aclaris Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Aclaris Therapeutics, Inc. -- SEC File Number
+ My List
ADIL Adial Pharmaceuticals, Inc - Common Stock 8.41% down 8.7% -0.29 + Biopharma, Disease: Addictions
- Alcohol
+ My List
ADMP Adamis Pharmaceuticals Corporation - Common Stock 7.48% up 3.74% 3.74 + Respiratory therapies / Pulmanory, Medicine, Biopharma

+ My List
AEZS Aeterna Zentaris Inc. - Common Stock 0 + Medicine, Disease: Endocrine disease, Biopharma

+ My List
ALIM Alimera Sciences, Inc. - Common Stock 9.05% up 4.07% 4.98 + Disease: Eye , Biopharma, Medicine

+ My List
ALRN Aileron Therapeutics, Inc. - Common Stock -6.84% up -7.69% 0.85 + Cancer fight, Medicine, Biopharma

+ My List
ALT Altimmune, Inc. - Common Stock 4.56% down 7.14% -2.58 + Immunology, Biopharma, Medicine


Last highlighted: #ALT SEC report: Altimmune, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Altimmune, Inc. -- SEC File Number
+ My List
ANCN Anchiano Therapeutics Ltd. - American Depositary Shares 0.00% 0 + Cancer fight, Biopharma, Medicine, Country: Israel

+ My List
ARTL Artelo Biosciences, Inc. - Common Stock 0 + Biopharma, Medicine

+ My List
ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock -8.66% -8.66% 0 + Biopharma, RNA, Medicine


Last highlighted: #ARWR SEC report: ARROWHEAD PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ARROWHEAD PHARMACEUTICALS, INC. -- SEC File Number 211148133
+ My List
ASLN ASLAN Pharmaceuticals Limited - American Depositary Shares -9.49% down -7.59% -1.9 + Country: Singapore, Pharmaceutical , Biopharma, Immunology, Medicine


Last highlighted: $ASLN / ASLAN Pharmaceuticals files form 6-K https://t.co/rm8jqdBSsq
+ My List
ASMB Assembly Biosciences, Inc. - Common Stock -3.51% up -9.65% 6.14 + Disease: Infectious, Medicine, Biopharma

+ My List
ATNX Athenex, Inc. - Common Stock -3.99% up -9.49% 5.5 + Cancer fight, Biopharma, Covid (fighting)

+ My List
AVIR Atea Pharmaceuticals, Inc. - common stock -10.19% down -7.72% -2.47 + Biopharma


Last highlighted: $AVIR Aviragen Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/JOpVDsaGT1
+ My List
AZRX AzurRx BioPharma, Inc. - Common Stock -6.34% up -9.33% 2.99 + Biopharma, Medicine, Disease: Gastrointestinal


Last highlighted: #AZRX SEC report: AzurRx BioPharma, Inc. Current report, item 5.02
SEC Filing Form 8-K filed by AzurRx BioPharma, Inc. -- SEC File Number 211083480
+ My List
BDSX Biodesix, Inc. - Common Stock 9.66% down 9.93% -0.27 + Biopharma, Medicine, Diagnosing, Disease: Lung


Last highlighted: A Form 8-K [Press/News Current Report] filing has been made with the SEC: $BDSX BIODESIX INC https://t.co/b5COJsaVls
+ My List
BLCM Bellicum Pharmaceuticals, Inc. - Common Stock -0.9% up -7.59% 6.69 + Biopharma, Medicine, Immunology


Last highlighted: #BLCM SEC report: BELLICUM PHARMACEUTICALS, INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by BELLICUM PHARMACEUTICALS, INC -- SEC File Number
+ My List
BNTC Benitec Biopharma Inc. - Common Stock 9.89% down 10.96% -1.07 + Biopharma, Biotechnology, RNA, Medicine, Gene and cell


Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q
+ My List
BTAI BioXcel Therapeutics, Inc. - Common Stock 2.29% up -11.25% 13.54 + Medicine, Immunology, Artificial Intelligence, Biopharma

+ My List
BVXV BiondVax Pharmaceuticals Ltd. - American Depositary Shares 10.67% up 9.33% 1.34 + Biopharma, Medicine, Disease: Infectious

+ My List
BXRX Baudax Bio, Inc. - Common stock -10.58% up -12.5% 1.92 + Surgery, Medicine, Biopharma

+ My List
BYSI BeyondSpring, Inc. - Ordinary Shares 0.48% down 7.69% -7.21 + Cancer fight, Biopharma, Medicine, Immunology


Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR
+ My List
CBIO Catalyst Biosciences, Inc. - Common Stock -8.17% down -3.85% -4.32 + Biopharma, Medicine


Last highlighted: #CBIO SEC report: CATALYST BIOSCIENCES, INC. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by CATALYST BIOSCIENCES, INC. -- SEC File Number 211147291
+ My List
CCXI ChemoCentryx, Inc. - Common Stock 0.71% up -7.2% 7.91 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01
+ My List
CDAK Codiak BioSciences, Inc. - Common Stock 7.52% up 4.08% 3.44 + Medicine, Biopharma

+ My List
CDNA CareDx, Inc. - Common Stock -5.72% up -9.28% 3.56 + Medicine, Biopharma, Transplant


Last highlighted: #CDNA SEC report: CareDx, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by CareDx, Inc. -- SEC File Number
+ My List
CHMA Chiasma, Inc. - Common Stock -6.86% -6.86% 0 + Biopharma, Medicine


Last highlighted: $AMYT 6-K Amryt Pharma (5 May, 8:45am) 📰 Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases https://t.co/30R4PU1D1d #AMYT #6K #AmrytPharma #News
+ My List
CLLS Cellectis S.A. - American Depositary Shares 9.62% 9.62% 0 + Biopharma, Medicine, Cancer fight

+ My List
CLRB Cellectar Biosciences, Inc. - Common Stock -7.41% up -9.26% 1.85 + Medicine, Biopharma, Cancer fight


Last highlighted: #CLRB SEC report: Cellectar Biosciences, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Cellectar Biosciences, Inc. -- SEC File Number 211087932
+ My List
CLSD Clearside Biomedical, Inc. - Common Stock -2.8% up -7.53% 4.73 + Disease: Eye , Medicine, Biopharma

+ My List
CNCE Concert Pharmaceuticals, Inc. - Common Stock 6.67% down 7.02% -0.35 + Biopharma, Medicine

+ My List
CTMX CytomX Therapeutics, Inc. - Common Stock 7.13% up 6.67% 0.46 + Biopharma, Cancer fight, Disease: Oncology
- Bad infrastructure
+ My List
CUE Cue Biopharma, Inc. - Common Stock -1.08% up -10.34% 9.26 + Biopharma, Immunology, Cancer fight

+ My List
CVAC CureVac N.V. - Ordinary Shares -7.9% up -8.34% 0.44 + Country: Germany, RNA, Medicine, Biopharma

+ My List
CYCC Cyclacel Pharmaceuticals, Inc. - Common Stock 3.06% down 7.03% -3.97 + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
+ My List
CYCCP Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock 0.13% down 8.41% -8.28 + Cancer fight, Medicine, Biopharma


Last highlighted: Filing Alert, FORM 8-K [Press/News Current Report] available. $CYCC $CYCCP #CyclacelPharmaceuticals, Inc. https://t.co/wcEcOgiN2c
+ My List
DBVT DBV Technologies S.A. - American Depositary Shares -7.07% -7.07% 0 + Immunology, Biopharma, Medicine


Last highlighted: #DBVT SEC report: DBV Technologies S.A. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by DBV Technologies S.A. -- SEC File Number 211136660
+ My List
DMAC DiaMedica Therapeutics Inc. - Common Stock -1.68% down 7.88% -9.56 + Biopharma, Disease: Kidney, Medicine, Disease: Acute ischemic stroke (AIS)

+ My List
DRNA Dicerna Pharmaceuticals, Inc. - Common Stock -2.89% -2.89% 0 + Biopharma, Pharmaceutical , RNA, Medicine


Last highlighted: $DRNA 📜 Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits https://t.co/pVex4DfvFC 30s delayed.
+ My List
DRRX DURECT Corporation - Common Stock 6.61% down 7.5% -0.89 + Biopharma, Disease: Liver, Medicine


Last highlighted: $DRRX New Form 8-K for DURECT Corporation From our Stock News Alerts App
+ My List
DVAX Dynavax Technologies Corporation - Common Stock 7.73% up 7.46% 0.27 + Immunology, Biology, Biopharma, Medicine, Vaccines


Last highlighted: #DVAX SEC report: DYNAVAX TECHNOLOGIES CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by DYNAVAX TECHNOLOGIES CORP -- SEC File Number
+ My List
DYAI Dyadic International, Inc. - Common Stock -9.18% -9.18% 0 + Medicine, Biopharma, Pharmaceutical

+ My List
EDSA Edesa Biotech, Inc. - Common Shares -2.55% up -7.55% 5 + Medicine, Biopharma, Immunology

+ My List
EIGR Eiger BioPharmaceuticals, Inc. - Common Stock -9.14% -9.14% 0 + Medicine, Biopharma


Last highlighted: #EIGR SEC report: Eiger BioPharmaceuticals, Inc. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Eiger BioPharmaceuticals, Inc. -- SEC File Number 211148434
+ My List
ELOX Eloxx Pharmaceuticals, Inc. - Common Stock -7.64% -7.64% 0 + Biopharma, Medicine, RNA

+ My List
ETNB 89bio, Inc. - Common Stock up -7.65% 7.65 + Biopharma, Disease: Liver, Medicine

+ My List
EYEN Eyenovia, Inc. - Common Stock -38.1% up -38.4% 0.3 + Medicine, Biopharma


Last highlighted: #EYEN SEC report: EYENOVIA, INC. [Amend] Statement of changes in beneficial ownership of securities
SEC Filing Form 4/A filed by EYENOVIA, INC. -- SEC File Number
+ My List
EYPT EyePoint Pharmaceuticals, Inc. - Common Stock 7.16% up 2.84% 4.32 + Pharmaceutical , Disease: Eye , Medicine, Biopharma


Last highlighted: #EYPT SEC report: EyePoint Pharmaceuticals, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by EyePoint Pharmaceuticals, Inc. -- SEC File Number 211142305
+ My List
FBIO Fortress Biotech, Inc. - Common Stock 6.95% down 9.6% -2.65 + Pharmaceutical , Biopharma, Biotechnology, Medicine

+ My List
FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock -0.12% -0.12% 0 + Medicine, Biotechnology, Biopharma

+ My List
FBRX Forte Biosciences, Inc. - Common Stock up -7.69% 7.69 + Skin, Medicine, Disease: Infectious, Biopharma

+ My List
FLXN Flexion Therapeutics, Inc. - Common Stock 0.88% up -7.21% 8.09 + Biopharma, Medicine, Disease: Musculoskeletal

+ My List
FOLD Amicus Therapeutics, Inc. - Common Stock -7.41% -7.41% 0 + Biopharma, Medicine


Last highlighted: #FOLD SEC report: AMICUS THERAPEUTICS, INC. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by AMICUS THERAPEUTICS, INC. -- SEC File Number 211148245
+ My List
FWP Forward Pharma A/S - American Depositary Shares 5.15% down 7.14% -1.99 + Country: Denmark, Biopharma, Disease: Neurology/Alzheimer/Parkinson's

+ My List
GLMD Galmed Pharmaceuticals Ltd. - Ordinary Shares -9.26% down -7.41% -1.85 + Disease: Liver, Biopharma, Country: Israel, Medicine


Last highlighted: Galmed Pharmaceuticals Ltd current quarter revenue growth YoY of 96.40% ranked 256 out of 5424 companies in our database. https://t.co/R7UW3RpPpw $GLMD 🚀🚀🚀🚀🚀 https://t.co/HVbvEgerWf
+ My List
GLSI Greenwich LifeSciences, Inc. - Common stock -7.71% up -8.3% 0.59 + Medicine, Biopharma, Cancer fight, Immunology

+ My List
GNFT GENFIT S.A. - American Depositary Shares 0.27% up -7.29% 7.56 + Biopharma, Disease: Liver, Medicine

+ My List
HGEN Humanigen, Inc. - Common Stock -59.04% down -58.97% -0.07 + Biopharma, Immunology, Cancer fight, Medicine


Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187
+ My List
HOTH Hoth Therapeutics, Inc. - Common Stock 5.43% down 8.53% -3.1 + Medicine, Biopharma, Skin

+ My List
ICPT Intercept Pharmaceuticals, Inc. - Common Stock 7.12% up 5.25% 1.87 + Pharmaceutical , Medicine, Biopharma, Disease: Liver


Last highlighted: #ICPT SEC report: INTERCEPT PHARMACEUTICALS, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by INTERCEPT PHARMACEUTICALS, INC. -- SEC File Number
+ My List
IMAB I-MAB - American Depositary Shares -0.65% -0.65% 0 + Country: China, Biopharma, Medicine


Last highlighted: $IMAB 📜 SEC Form 6-K filed by I-MAB https://t.co/B5768Avydp #majorpharmaceuticals #healthcare
+ My List
IMRN Immuron Limited - American Depositary Shares 0.56% 0.56% 0 + Biotechnology, Country: Australia, Biopharma, Medicine


Last highlighted: $IMRN 📜 SEC Form 6-K filed by Immuron Limited https://t.co/xsrBOQcQ0a
+ My List
IMV IMV Inc. - Common Shares 6.71% down 7.32% -0.61 + Immunology, Medicine, Country: Canada, Covid (fighting), Biopharma


Last highlighted: #IMV SEC report: IMV Inc. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by IMV Inc. -- SEC File Number 211138178
+ My List
INSM Insmed, Inc. - Common Stock -8.72% -8.72% 0 + Biopharma, Medicine

+ My List
ISEE IVERIC bio, Inc. - Common Stock -4.54% up -9.73% 5.19 + Medicine, Biopharma


Last highlighted: #ISEE SEC report: IVERIC bio, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IVERIC bio, Inc. -- SEC File Number 211142256
+ My List
ITOS iTeos Therapeutics, Inc. - Common Stock -1.42% -1.42% 0 + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine


Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement https://t.co/fsH6i8bthL 15s delayed.
+ My List
JAGX Jaguar Health, Inc. - Common Stock 11.89% up 8.65% 3.24 + Medicine, Biopharma, Agritech

+ My List
KALA Kala Pharmaceuticals, Inc. - Common Stock -8.78% -8.78% 0 + Disease: Eye , Disease: Gastrointestinal, Medicine, Biopharma

+ My List
KIN Kindred Biosciences, Inc. - Common Stock 45.43% down 45.74% -0.31 + Animals, Biopharma, Biotechnology, Medicine, Pets


Last highlighted: #KIN SEC report: Kindred Biosciences, Inc. Definitive proxy statement relating to merger or acquisition
SEC Filing Form DEFM14A filed by Kindred Biosciences, Inc. -- SEC File Number 211102924
+ My List
KMDA Kamada Ltd. - Ordinary Shares 6.53% down 9.97% -3.44 + Biopharma, Pharmaceutical , Medicine


Last highlighted: #KMDA SEC report: KAMADA LTD Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by KAMADA LTD -- SEC File Number 211161938
+ My List
KNSA Kiniksa Pharmaceuticals, Ltd. - Class A Common Stock 0.23% up -8.75% 8.98 + Pharmaceutical , Biopharma, Medicine


Last highlighted: #KNSA SEC report: Kiniksa Pharmaceuticals, Ltd. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kiniksa Pharmaceuticals, Ltd. -- SEC File Number 211138062
+ My List
KOD Kodiak Sciences Inc - Common Stock -7.08% down -7.02% -0.06 + Biopharma, Disease: Eye , Medicine

+ My List
KRBP Kiromic BioPharma, Inc. - Common Stock 17.19% up 13.02% 4.17 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals
+ My List
KROS Keros Therapeutics, Inc. - common stock 3.1% up -7.85% 10.95 + Biopharma, Medicine, Hematologic and musculoskeletal disorders


Last highlighted: #KROS SEC report: Keros Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Keros Therapeutics, Inc. -- SEC File Number 211148197
+ My List
KYMR Kymera Therapeutics, Inc. - Common Stock 6.95% down 7.73% -0.78 + Biopharma, Medicine


Last highlighted: #KYMR SEC report: Kymera Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Kymera Therapeutics, Inc. -- SEC File Number
+ My List
LJPC La Jolla Pharmaceutical Company - Common Stock 6.45% down 7.2% -0.75 + Medicine, Biopharma


Last highlighted: #LJPC SEC report: LA JOLLA PHARMACEUTICAL CO Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by LA JOLLA PHARMACEUTICAL CO -- SEC File Number
+ My List
MDWD MediWound Ltd. - Ordinary Shares 10.16% up 6.32% 3.84 + Biopharma

+ My List
MITO Stealth BioTherapeutics Corp. - American Depositary Shares 1.68% down 11.38% -9.7 + Medicine, Biopharma, Disease: Eye

+ My List
MNPR Monopar Therapeutics Inc. - Common Stock 1.32% up -8.82% 10.14 + Cancer fight, Medicine, Biopharma


Last highlighted: #MNPR SEC report: Monopar Therapeutics Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Monopar Therapeutics -- SEC File Number 211138054
+ My List
MOR MorphoSys AG - American Depositary Shares -0.8% down 7.8% -8.6 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight

+ My List
MREO Mereo BioPharma Group plc - American Depositary Shares -0.86% up -11.41% 10.55 + Biopharma, Cancer fight, Country: Greate Britain


Last highlighted: #MREO SEC report: Mereo Biopharma Group plc Registration statement by foreign private issuers
SEC Filing Form F-3 filed by Mereo Biopharma Group plc -- SEC File Number 211148904
+ My List
NGM NGM Biopharmaceuticals, Inc. - Common Stock -0.68% -0.68% 0 + Biopharma, Medicine


Last highlighted: $NGM 📜 NGM Biopharmaceuticals, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits https://t.co/NbDnNxMZQc #majorpharmaceuticals #healthcare
+ My List
NMTR 9 Meters Biopharma, Inc. - Common Stock 0.76% up -8.39% 9.15 + Biopharma, Medicine, Disease: Bowel syndrome, Disease: Celiac


Last highlighted: #NMTR SEC report: 9 METERS BIOPHARMA, INC. Current report, items 1.01, 2.01, 8.01, and 9.01
SEC Filing Form 8-K filed by 9 METERS BIOPHARMA, INC. -- SEC File Number 211096936
+ My List
NTEC Intec Pharma Ltd. - Ordinary Shares -10.36% -10.36% 0 + Biopharma, Medicine, Cannabis

+ My List
NTLA Intellia Therapeutics, Inc. - Common Stock -1.97% up -10.59% 8.62 + Medicine, Gene and cell, Biotechnology, Biopharma

+ My List
OCUP Ocuphire Pharma, Inc. - Common Stock -2.61% -2.61% 0 + Disease: Eye , Biopharma, Medicine, Pharmaceutical


Last highlighted: $OCUP 📜 Ocuphire Pharma, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits https://t.co/xMAN0ucl8b 15s delayed.
+ My List
OMER Omeros Corporation - Common Stock -2.7% down 7.24% -9.94 + Biopharma, Biotechnology, Medicine


Last highlighted: #OMER SEC report: OMEROS CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by OMEROS CORP -- SEC File Number
+ My List
OSMT Osmotica Pharmaceuticals plc - Ordinary Shares -1.47% down 7.45% -8.92 + Pharmaceutical , Women Health, Biopharma

+ My List
OTLK Outlook Therapeutics, Inc. - Common Stock 4.21% down 7.01% -2.8 + Disease: Eye , Biopharma, Medicine


Last highlighted: #OTLK SEC report: Outlook Therapeutics, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by Outlook Therapeutics, Inc. -- SEC File Number
+ My List
PGEN Precigen, Inc. - Common Stock 9.55% 9.55% 0 + Biopharma, Gene and cell, Medicine


Last highlighted: #PGEN SEC report: PRECIGEN, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PRECIGEN, INC. -- SEC File Number
+ My List
PIRS Pieris Pharmaceuticals, Inc. - Common Stock -2.91% up -7.38% 4.47 + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight


Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334
+ My List
PLRX Pliant Therapeutics, Inc. - Common Stock -22.89% -22.89% 0 + Biopharma, Medicine

+ My List
PRAX Praxis Precision Medicines, Inc. - Common Stock 6.26% down 7.29% -1.03 + Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine


Last highlighted: Research Analysts Set Expectations for Praxis Precision Medicines, Inc.’s Q1 2022 Earnings $PRAX https://t.co/u6zv6m9Tyz #markets
+ My List
PRTK Paratek Pharmaceuticals, Inc. - Common Stock -7.84% up -8.82% 0.98 + Pharmaceutical , Biopharma, Medicine, Life Sciences

+ My List
RGLS Regulus Therapeutics Inc. - Common Stock 0 + RNA, Biopharma, Medicine

+ My List
RZLT Rezolute, Inc. - Common Stock 2.3% down 8.63% -6.33 + Biopharma, Medicine, Disease: Hypoglycemia


Last highlighted: #RZLT SEC report: Rezolute, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Rezolute, Inc. -- SEC File Number 211161853
+ My List
SAVA Cassava Sciences, Inc. - Common Stock 4.59% down 8.07% -3.48 + Disease: Neurology/Alzheimer/Parkinson's, Medicine, Biopharma

+ My List
SNSS Sunesis Pharmaceuticals, Inc. - Common Stock 0.00% 0 + Medicine, Biopharma, Cancer fight

+ My List
SPRO Spero Therapeutics, Inc. - Common Stock -7.78% down -7.51% -0.27 + Disease: Infectious, Biopharma, Medicine

+ My List
TCON TRACON Pharmaceuticals, Inc. - Common Stock 0.25% down 8.53% -8.28 + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology

+ My List
THTX Theratechnologies Inc. - Common Shares -2.17% down 11.67% -13.84 + Cancer fight, Biopharma, Medicine

+ My List
TLRY Tilray, Inc. - Class 2 Common Stock -6.85% up -7.27% 0.42 + Biopharma, Cannabis, Medicine, Country: Canada, Reddit's Wave


Last highlighted: #TLRY SEC report: Tilray, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Tilray, Inc. -- SEC File Number
+ My List
TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock up -35.29% 35.29 + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)


Last highlighted: $TNXP TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure https://t.co/hFCRf3OmpX
+ My List
TRVN Trevena, Inc. - Common Stock -6.72% up -7.46% 0.74 + Biopharma, Medicine, Disease: Central nervous system (CNS)


Last highlighted: $TRVN Trading is easy with Buy and Short signals displayed on the chart https://t.co/optkvg9qmr
+ My List
TTNP Titan Pharmaceuticals, Inc. - Common Stock 5.68% down 9.66% -3.98 + Biopharma, Disease: Central nervous system (CNS), Medicine

+ My List
VBLT Vascular Biogenics Ltd. - Ordinary Shares -11.3% -11.3% 0 + Country: Israel, Biopharma, Cancer fight, Medicine

+ My List
VCEL Vericel Corporation - Common Stock -7.16% up -7.35% 0.19 + Biopharma, Medicine, Sport

+ My List
VSTM Verastem, Inc. - Common Stock 3.04% down 8.11% -5.07 + Biopharma, Cancer fight, Medicine


Last highlighted: #VSTM SEC report: Verastem, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Verastem, Inc. -- SEC File Number 211136620
+ My List
WINT Windtree Therapeutics, Inc. - Common Stock -11.56% up -15.56% 4 + Biopharma, Respiratory therapies / Pulmanory, Medicine

+ My List
XAIR Beyond Air, Inc. - Common Stock -2.74% up -8.22% 5.48 + Respiratory therapies / Pulmanory, Medicine, Biopharma

+ My List
XBIO Xenetic Biosciences, Inc. - Common Stock 4.47% down 7.82% -3.35 + Biopharma, Cancer fight, Disease: Oncology, Medicine

+ My List
YMAB Y-mAbs Therapeutics, Inc. - Common Stock 0.03% down 7.31% -7.28 + Biopharma, Cancer fight, Medicine


Last highlighted: #YMAB SEC report: Y-mAbs Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Y-mAbs Therapeutics, Inc. -- SEC File Number 211148421
+ My List
ZSAN Zosano Pharma Corporation - Common Stock 0 + Biopharma, Medicine

+ My List
GTBP GT Biopharma, Inc. - Common Stock 7.35% 7.35% 0 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight


Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131
+ My List
LABP Landos Biopharma, Inc. - Common Stock -1.68% up -8.72% 7.04 + Biopharma, Medicine

+ My List
LEXX Lexaria Bioscience Corp. - Common Stock 6.71% down 7.38% -0.67 + Biopharma, Medicine, Cannabinoid-based


Last highlighted: #LEXX SEC report: Lexaria Bioscience Corp. Current report, item 8.01
+ My List
MASS 908 Devices Inc. - Common Stock -6.42% up -7.09% 0.67 + Devices, Biopharma, Life Sciences


Last highlighted: #MASS SEC report: 908 Devices Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by 908 Devices Inc. -- SEC File Number 211142324
+ My List
SCPS Scopus BioPharma Inc. - Common Stock -6.79% up -7.69% 0.9 + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma


Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB
+ My List
TERN Terns Pharmaceuticals, Inc. - Common Stock -0.21% -0.21% 0 + Biopharma, Pharmaceutical , Disease: Liver


Last highlighted: $TERN 8-K Terns Pharmaceuticals (14 Jun, 4:40pm) 📰 Terns Reports Positive Top-line Results from Phase 2a LIFT Study of FXR Agonist TERN-101 in Patients with NASH https://t.co/wJNwFxLOZw #TERN #8K #TernsPharmaceuticals #News
+ My List
TVTX Travere Therapeutics, Inc. - Common Stock 7.5% down 8.62% -1.12 + Biopharma, Medicine

+ My List
VINC Vincerx Pharma, Inc. - Common Stock 5.33% down 7.34% -2.01 + Biopharma, Medicine, Life Sciences

+ My List
VOR Vor Biopharma Inc. - Common Stock 8.27% 8.27% 0 + Biopharma, Medicine, Cancer fight, Disease: Oncology

+ My List
CNTB Connect Biopharma Holdings Limited - American Depositary Shares -2.57% up -3.68% 1.11 + Biopharma, Country: China, T cell-based


Last highlighted: $CNTB 6-K Connect Biopharma (16 Jun, 4:01pm) 📰 Current report (foreign) https://t.co/U5Q30mPOFH #CNTB #6K #ConnectBiopharma #News
+ My List
OLK Olink Holding AB (publ) - American Depositary Shares 8.33% 8.33% 0 + Biology, Biopharma, Medicine, Country: Sweden


Last highlighted: #OLK SEC report: Olink Holding AB Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Olink Holding AB -- SEC File Number 211161931
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.